Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02758574 · ClinicalTrials.gov registry record · NA
Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02758574: Completed NA study, sponsored by University of Pittsburgh.
NCT02758574 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02758574, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE). The study population will include patients eligible for catheter directed thrombolysis (CDT) for submassive PE. Subjects will be randomized to, either, standard catheter-directed thrombolysis or ultrasound-accelerated thrombolysis (USAT).
Interventions
- PROCEDURE CDT without ultrasound acceleration
- PROCEDURE CDT with ultrasound acceleration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-08 |
| Phase | NA |
What the finished NCT02758574 record still lists
NCT02758574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which CDT without ultrasound acceleration is the first listed.
NCT02758574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02758574 about?
NCT02758574 is a clinical study titled "Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism". The study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE). The study population will include patients eligible for catheter directed thrombolysis (CDT) for submassive PE. Subjects will be random...
What is the current status of trial NCT02758574?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-05. Estimated completion is 2021-08.
What interventions are being tested in trial NCT02758574?
The interventions under investigation include: CDT without ultrasound acceleration (PROCEDURE), CDT with ultrasound acceleration (PROCEDURE).
Who is sponsoring clinical trial NCT02758574?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02758574's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia